PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
28-Feb-2023 Laevoroc Immunology Announces FDA Orphan Drug Designation Granted to LR 09, a Novel Metabolic Immune Checkpoint Inhibitor for the Treatment of Leukemia Relapse after Allogeneic Stem Cell Transplant Laevoroc Immunology
28-Feb-2023 OKYO Pharma Announces Custom Clearance of GMP Packaged OK-101 Drug to be Used in Phase 2 Clinical Trial for Treating Dry Eye Disease OKYO Pharma
28-Feb-2023 ABPI response to the new Northern Ireland Brexit deal ABPI
28-Feb-2023 Rare and orphan disease expert Terebellum launches market access guide Terebellum
28-Feb-2023 mdgroup launches third fully compliant medical distribution centre in Europe mdgroup
28-Feb-2023 ValGenesis & Rephine Partner to Deliver Digital End-to-End Compliance Solutions for Life Sciences Companies ValGenesis
28-Feb-2023 PharmiWeb.Jobs Announces New Recruitment Training Courses PharmiWeb.Jobs
28-Feb-2023 MediClin AG: Disclosure of the preliminary figures of the 2022 financial year MediClin AG
28-Feb-2023 PharmiWeb.Jobs Welcomes Chameleon International Chameleon International
28-Feb-2023 PureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD) PureTech Health plc
28-Feb-2023 Rhythm Pharmaceuticals Announces Acquisition of Xinvento B.V. and Portfolio of Investigational Therapeutics Rhythm Pharmaceuticals
28-Feb-2023 Carterra expands best-in-class franchise with the launch of the LSAXT high-throughput SPR biosensor at SLAS 2023 Carterra
28-Feb-2023 serYmun Yeast Announces Preclinical Safety and Efficacy Data for Their Yeast-Based Vaccine Against Porcine Parvovirus (PPV) serYmun Yeast
28-Feb-2023 Darolutamide receives approval for additional prostate cancer indication in Japan ORION CORPORATION
28-Feb-2023 New Phase 3 data presented at WORLDSymposiumâ„¢ reinforce Nexviazyme® (avalglucosidase alfa) as potential new standard of care for all people living with late-onset Pompe disease Sanofi
28-Feb-2023 Alfa Laval Launches Best-in-class Heat Exchanger for Hygienic Applications Alfa Laval
28-Feb-2023 Almirall opens the doors of its R&D centre to the biotech ZeClinics Almirall
28-Feb-2023 HUTCHMED Completes Patient Enrollment of Phase II Registration Trial of Amdizalisib in Follicular Lymphoma in China HUTCHMED
28-Feb-2023 Obesity in pregnant women could alter the structure and function of the placenta increasing the risk of poor health outcomes for both mother and baby The Physiological Society
28-Feb-2023 Final Results Spectral MD Holdings, Ltd